Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19
Am J Emerg Med
.
2023 Mar:65:214-215.
doi: 10.1016/j.ajem.2022.12.027.
Epub 2022 Dec 22.
Authors
Qian Zheng
1
,
Pengfei Ma
1
,
Zhanhui Feng
2
Affiliations
1
Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
2
Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, China. Electronic address: h9450203@126.com.
PMID:
36577594
PMCID:
PMC9771576
DOI:
10.1016/j.ajem.2022.12.027
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents
COVID-19 Drug Treatment
COVID-19*
Humans
Ritonavir
Substances
nirmatrelvir
Ritonavir
Antiviral Agents